Research programme: echinacea-derived immunostimulating compounds - MolecularNature LimitedAlternative Names: Echinacea-derived bio-active compounds - MolecularNature Limited; Echinacea-derived immunostimulating compounds - MolecularNature Limited
Latest Information Update: 20 Sep 2011
At a glance
- Originator MNLpharma
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Autoimmune disorders
Most Recent Events
- 06 Sep 2005 Preclinical trials in Autoimmune disorders in USA (unspecified route)